Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03760757 · ClinicalTrials.gov registry record · NA
Effectiveness of Two Different Forms of Marine Oil on Indirect Markers of Muscle Damage and Soreness in Untrained Men
A NA study of Inflammation; Muscle, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT03760757 is a NA study of Inflammation; Muscle that has completed, run by Indiana University. The registered enrollment target is 57 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03760757, a NA study of Inflammation; Muscle, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the effects of PCSO-524®, and a blend of PCSO-24® (75%) and krill oil (25%) (ESPO-572®), on indirect markers of muscle damage, inflammation and soreness during recovery from muscle damaging exercise in untrained men.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT ESPO-572®
- DIETARY_SUPPLEMENT PCSO-524®
Study Locations (1)
Indiana
- Indiana University School of Public Health - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2019-02-11 |
| Est. Completion | 2019-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03760757
The ClinicalTrials.gov registry entry for NCT03760757 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inflammation; Muscle appearing as the primary indexed condition, and to 2 interventions - of which ESPO-572® is the first listed.
NCT03760757 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT03760757 about?
NCT03760757 is a clinical study titled "Effectiveness of Two Different Forms of Marine Oil on Indirect Markers of Muscle Damage and Soreness in Untrained Men". To evaluate the effects of PCSO-524®, and a blend of PCSO-24® (75%) and krill oil (25%) (ESPO-572®), on indirect markers of muscle damage, inflammation and soreness during recovery from muscle damaging exercise in untrained men.
What is the current status of trial NCT03760757?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2019-02-11. Estimated completion is 2019-08-30.
What conditions does trial NCT03760757 study?
This clinical trial studies the following conditions: Inflammation; Muscle.
What interventions are being tested in trial NCT03760757?
The interventions under investigation include: ESPO-572® (DIETARY_SUPPLEMENT), PCSO-524® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03760757?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03760757 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.